Literature DB >> 8648818

Transperineal photodynamic ablation of the canine prostate.

S H Selman1, R W Keck, J A Hampton.   

Abstract

PURPOSE: Experiments were undertaken to determine the effects of transperineal interstitial photodynamic therapy on the canine prostate.
MATERIALS AND METHODS: Mongrel dogs were injected intravenously with the photosensitizer, tin (II) ethyl etiopurpurin dichloride. Twenty-four hours later, 2 optical fibers were implanted in 1 hemisphere of the prostate, which was then treated with red light (660 nm.).
RESULTS: Acutely, the treated areas showed extensive hemorrhagic necrosis. At 3 and 6 weeks, the treated lobes were largely replaced by fibrous connective tissue.
CONCLUSION: Transperineal photodynamic therapy of the canine prostate is feasible. Further preclinical investigation is warranted to determine the applicability of this approach to the treatment of localized prostate cancer.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8648818

Source DB:  PubMed          Journal:  J Urol        ISSN: 0022-5347            Impact factor:   7.450


  13 in total

1.  Effects of Pd-bacteriopheophorbide (TOOKAD)-mediated photodynamic therapy on canine prostate pretreated with ionizing radiation.

Authors:  Zheng Huang; Qun Chen; Nadira Trncic; Susan M LaRue; Pierre-Hervé Brun; Brian C Wilson; Howard Shapiro; Fred W Hetzel
Journal:  Radiat Res       Date:  2004-06       Impact factor: 2.841

Review 2.  Photodynamic therapy for focal ablation of the prostate.

Authors:  Nimalan Arumainayagam; C M Moore; Hashim U Ahmed; M Emberton
Journal:  World J Urol       Date:  2010-05-09       Impact factor: 4.226

3.  Effects of photodynamic therapy on peripheral nerve: in situ compound-action potentials study in a canine model.

Authors:  Kenneth C Dole; Qun Chen; Fred W Hetzel; Lawrence R Whalen; Dominique Blanc; Zhen Huang
Journal:  Photomed Laser Surg       Date:  2005-04       Impact factor: 2.796

4.  The effect of Tookad-mediated photodynamic ablation of the prostate gland on adjacent tissues--in vivo study in a canine model.

Authors:  Zheng Huang; Qun Chen; Kenneth C Dole; Al B Barqawi; Yang K Chen; Dominique Blanc; Brian C Wilson; Fred W Hetzel
Journal:  Photochem Photobiol Sci       Date:  2007-08-22       Impact factor: 3.982

5.  Prostate PDT dosimetry.

Authors:  Timothy C Zhu; Jarod C Finlay
Journal:  Photodiagnosis Photodyn Ther       Date:  2006-10-19       Impact factor: 3.631

6.  Ferritin nanocages to encapsulate and deliver photosensitizers for efficient photodynamic therapy against cancer.

Authors:  Zipeng Zhen; Wei Tang; Cunlan Guo; Hongmin Chen; Xin Lin; Gang Liu; Baowei Fei; Xiaoyuan Chen; Binqian Xu; Jin Xie
Journal:  ACS Nano       Date:  2013-07-11       Impact factor: 15.881

7.  Optical properties of human prostate at 732 nm measured in mediated photodynamic therapy.

Authors:  Timothy C Zhu; Andreea Dimofte; Jarod C Finlay; Diana Stripp; Theresa Busch; Jeremy Miles; Richard Whittington; S Bruce Malkowicz; Zelig Tochner; Eli Glatstein; Stephen M Hahn
Journal:  Photochem Photobiol       Date:  2005 Jan-Feb       Impact factor: 3.421

8.  Studies of a vascular-acting photosensitizer, Pd-bacteriopheophorbide (Tookad), in normal canine prostate and spontaneous canine prostate cancer.

Authors:  Zheng Huang; Qun Chen; David Luck; Jill Beckers; Brian C Wilson; Nadira Trncic; Susan M Larue; Dominique Blanc; Fred W Hetzel
Journal:  Lasers Surg Med       Date:  2005-06       Impact factor: 4.025

9.  Determination of the distribution of light, optical properties, drug concentration, and tissue oxygenation in-vivo in human prostate during motexafin lutetium-mediated photodynamic therapy.

Authors:  Timothy C Zhu; Jarod C Finlay; Stephen M Hahn
Journal:  J Photochem Photobiol B       Date:  2004-12-02       Impact factor: 6.252

Review 10.  Photodynamic therapy: a new approach to prostate cancer.

Authors:  Rolf Muschter
Journal:  Curr Urol Rep       Date:  2003-06       Impact factor: 2.862

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.